Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 327,214 | 402,579 | 758,505 | 278,887 | 164,269 |
| Marketable Securities | 779,246 | 982,725 | 531,604 | 425,491 | 353,680 |
| Receivables | N/A | N/A | 3,112 | 8,542 | N/A |
| Other current assets | 12,826 | 13,931 | 8,377 | 3,085 | 0 |
| TOTAL | $1,152,174 | $1,418,997 | $1,322,769 | $724,214 | $523,965 |
| Non-Current Assets | |||||
| PPE Net | 151,176 | 246,622 | 199,606 | 156,955 | 82,614 |
| Investments And Advances | 131,506 | 506,123 | 324,193 | 180,452 | 347,814 |
| Intangibles | 27,454 | 26,297 | 30,059 | 33,822 | 37,584 |
| Other Non-Current Assets | 265,114 | 44,805 | 23,940 | 22,679 | 10,360 |
| TOTAL | $575,250 | $823,847 | $577,798 | $393,908 | $478,372 |
| Total Assets | $1,727,424 | $2,242,844 | $1,900,567 | $1,118,122 | $1,002,337 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 42,995 | 17,831 | 12,873 | 13,664 | 6,334 |
| Accrued Expenses | 141,556 | 99,393 | 57,065 | 54,660 | 28,145 |
| Other current liabilities | 10,380 | 10,605 | N/A | N/A | N/A |
| TOTAL | $223,580 | $146,431 | $95,612 | $74,533 | $40,368 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 153,319 | N/A | N/A | N/A |
| Deferred Revenues | 8,474 | 18,602 | 25,674 | 6,209 | 5,889 |
| Other Non-Current Liabilities | 209,060 | 41,686 | 159,760 | 123,537 | 67,220 |
| TOTAL | $218,851 | $211,343 | $181,523 | $174,149 | $111,473 |
| Total Liabilities | $442,431 | $357,774 | $277,135 | $248,682 | $151,841 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,781 | 2,748 | 2,499 | 2,042 | 1,846 |
| Common Shares | 554 | 547 | 494 | 407 | 369 |
| Retained earnings | -2,281,852 | -1,498,808 | -913,808 | -577,674 | -314,167 |
| Other shareholders' equity | -1,893 | -3,627 | -4,205 | -1,149 | -2,291 |
| TOTAL | $1,284,993 | $1,885,070 | $1,623,432 | $869,440 | $850,496 |
| Total Liabilities And Equity | $1,727,424 | $2,242,844 | $1,900,567 | $1,118,122 | $1,002,337 |